{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:19:20Z","timestamp":1791317960868,"version":"4.3.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"DOI":"10.1007\/s11906-025-01356-1","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T09:48:07Z","timestamp":1767433687000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Obstructive Sleep Apnea and Hypertension: Is Aldosterone Blockade the Optimal Approach to Control Blood Pressure and Improve Oxygenation?"],"prefix":"10.1007","volume":"28","author":[{"given":"Allison K.","family":"Ikeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,3]]},"reference":[{"issue":"8","key":"1356_CR1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S2213-2600(19)30198-5","volume":"7","author":"AV Benjafield","year":"2019","unstructured":"Benjafield AV, Ayas NT, Eastwood PR, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019;7(8):687\u201398.","journal-title":"Lancet Respir Med"},{"issue":"2","key":"1356_CR2","doi-asserted-by":"publisher","first-page":"190","DOI":"10.7326\/0003-4819-103-2-190","volume":"103","author":"FLETCHEREC DeBEHNKE","year":"1985","unstructured":"DeBEHNKE FLETCHEREC, LOVOI RD. Undiagnosed sleep apnea in patients with essential hypertension. Ann Intern Med. 1985;103(2):190\u20135.","journal-title":"Ann Intern Med"},{"issue":"2","key":"1356_CR3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0002-8703(84)90628-8","volume":"108","author":"P Lavie","year":"1984","unstructured":"Lavie P, Ben-Yosef R, Rubin AE. Prevalence of sleep apnea syndrome among patients with essential hypertension. Am Heart J. 1984;108(2):373\u20136.","journal-title":"Am Heart J"},{"issue":"1","key":"1356_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1164\/ajrccm.157.1.9609063","volume":"157","author":"CJ Worsnop","year":"1998","unstructured":"Worsnop CJ, Naughton MT, Barter CE, Morgan TO, Anderson AI, Pierce RJ. The prevalence of obstructive sleep apnea in hypertensives. Am J Respir Crit Care Med. 1998;157(1):111\u20135.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"1356_CR5","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.amjcard.2009.12.017","volume":"105","author":"LF Drager","year":"2010","unstructured":"Drager LF, Genta PR, Pedrosa RP, et al. Characteristics and predictors of obstructive sleep apnea in patients with systemic hypertension. Am J Cardiol. 2010;105(8):1135\u20139.","journal-title":"Am J Cardiol"},{"issue":"5","key":"1356_CR6","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1161\/CIRCRESAHA.125.325676","volume":"137","author":"E Tasali","year":"2025","unstructured":"Tasali E, Pamidi S, Covassin N, Somers VK. Obstructive sleep apnea and cardiometabolic disease: obesity, hypertension, and diabetes. Circ Res. 2025;137(5):764\u201387.","journal-title":"Circ Res"},{"issue":"14","key":"1356_CR7","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1001\/jama.283.14.1829","volume":"283","author":"FJ Nieto","year":"2000","unstructured":"Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep heart health study. JAMA. 2000;283(14):1829\u201336.","journal-title":"JAMA"},{"issue":"15","key":"1356_CR8","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1001\/archinte.160.15.2289","volume":"160","author":"EO Bixler","year":"2000","unstructured":"Bixler EO, Vgontzas AN, Lin HM, et al. Association of hypertension and sleep-disordered breathing. Arch Intern Med. 2000;160(15):2289\u201395.","journal-title":"Arch Intern Med"},{"issue":"19","key":"1356_CR9","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1056\/NEJM200005113421901","volume":"342","author":"PE Peppard","year":"2000","unstructured":"Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342(19):1378\u201384.","journal-title":"N Engl J Med"},{"key":"1356_CR10","unstructured":"Members* WC, Jones DW, Ferdinand KC, et al. 2025 AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025;152(11):e114-e218."},{"issue":"7","key":"1356_CR11","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/S0002-9343(00)00614-8","volume":"109","author":"NS Cherniack","year":"2000","unstructured":"Cherniack NS. New mechanisms for the cardiovascular effects of sleep apnea. Am J Med. 2000;109(7):592\u20134.","journal-title":"Am J Med"},{"issue":"13","key":"1356_CR12","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.jacc.2024.02.059","volume":"84","author":"S Javaheri","year":"2024","unstructured":"Javaheri S, Javaheri S, Somers VK, et al. Interactions of obstructive sleep apnea with the pathophysiology of cardiovascular disease, part 1. J Am Coll Cardiol. 2024;84(13):1208\u201323.","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"1356_CR13","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.jacc.2024.07.024","volume":"84","author":"S Javaheri","year":"2024","unstructured":"Javaheri S, Javaheri S, Gozal D, et al. Treatment of OSA and its impact on cardiovascular Disease, part 2: JACC State-of-the-Art review. J Am Coll Cardiol. 2024;84(13):1224\u201340.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"1356_CR14","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1164\/rccm.202507-1574ST","volume":"211","author":"TM Tolbert","year":"2025","unstructured":"Tolbert TM, Schmickl CN, Gell LK, et al. Research priorities for translating endophenotyping of adult obstructive sleep apnea to the clinic: an official American thoracic society research statement. Am J Respir Crit Care Med. 2025;211(9):1562\u201383.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"1356_CR15","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1038\/s41440-024-01852-y","volume":"47","author":"K Shiina","year":"2024","unstructured":"Shiina K. Obstructive sleep apnea -related hypertension: a review of the literature and clinical management strategy. Hypertens Res. 2024;47(11):3085\u201398.","journal-title":"Hypertens Res"},{"issue":"4","key":"1356_CR16","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1172\/JCI118235","volume":"96","author":"VK Somers","year":"1995","unstructured":"Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995;96(4):1897\u2013904.","journal-title":"J Clin Invest"},{"issue":"1","key":"1356_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1183\/09031936.00204209","volume":"37","author":"R Tamisier","year":"2011","unstructured":"Tamisier R, P\u00e9pin JL, R\u00e9my J, et al. 14 nights of intermittent hypoxia elevate daytime blood pressure and sympathetic activity in healthy humans. Eur Respir J. 2011;37(1):119\u201328.","journal-title":"Eur Respir J"},{"issue":"3","key":"1356_CR18","doi-asserted-by":"publisher","first-page":"H925","DOI":"10.1152\/ajpheart.00253.2009","volume":"299","author":"GS Gilmartin","year":"2010","unstructured":"Gilmartin GS, Lynch M, Tamisier R, Weiss JW. Chronic intermittent hypoxia in humans during 28 nights results in blood pressure elevation and increased muscle sympathetic nerve activity. Am J Physiol Heart Circ Physiol. 2010;299(3):H925\u2013931.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6 Pt 2","key":"1356_CR19","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1161\/01.HYP.11.6.608","volume":"11","author":"VK Somers","year":"1988","unstructured":"Somers VK, Mark AL, Abboud FM. Potentiation of sympathetic nerve responses to hypoxia in borderline hypertensive subjects. Hypertension. 1988;11(6 Pt 2):608\u201312.","journal-title":"Hypertension"},{"issue":"6","key":"1356_CR20","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1152\/jappl.1990.69.6.2143","volume":"69","author":"J Ringler","year":"1990","unstructured":"Ringler J, Basner RC, Shannon R, et al. Hypoxemia alone does not explain blood pressure elevations after obstructive apneas. J Appl Physiol. 1990;69(6):2143\u20138.","journal-title":"J Appl Physiol"},{"issue":"3","key":"1356_CR21","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1152\/japplphysiol.00749.2003","volume":"96","author":"DM O\u2019Driscoll","year":"2004","unstructured":"O\u2019Driscoll DM, Meadows GE, Corfield DR, Simonds AK, Morrell MJ. Cardiovascular response to arousal from sleep under controlled conditions of central and peripheral chemoreceptor stimulation in humans. J Appl Physiol. 2004;96(3):865\u201370.","journal-title":"J Appl Physiol"},{"issue":"1","key":"1356_CR22","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/HJH.0000000000001134","volume":"35","author":"C Janssen","year":"2017","unstructured":"Janssen C, Pathak A, Grassi G, van de Borne P. Endothelin contributes to the blood pressure rise triggered by hypoxia in severe obstructive sleep apnea. J Hypertens. 2017;35(1):118\u201324.","journal-title":"J Hypertens"},{"issue":"7","key":"1356_CR23","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1164\/ajrccm.165.7.2202030c","volume":"165","author":"NR Prabhakar","year":"2002","unstructured":"Prabhakar NR. Sleep apneas: an oxidative stress? Am J Respir Crit Care Med. 2002;165(7):859\u201360.","journal-title":"Am J Respir Crit Care Med"},{"key":"1356_CR24","doi-asserted-by":"crossref","unstructured":"Pengo MF, Soranna D, Giontella A et al. Obstructive sleep Apnoea treatment and blood pressure: which phenotypes predict a response? A systematic review and meta-analysis. Eur Respir J. 2020;55(5):1\u201314.","DOI":"10.1183\/13993003.01945-2019"},{"issue":"9349","key":"1356_CR25","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","volume":"360","author":"S Lewington","year":"2002","unstructured":"Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903\u201313.","journal-title":"Lancet"},{"issue":"5","key":"1356_CR26","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1097\/HJH.0000000000003694","volume":"42","author":"M Seidel","year":"2024","unstructured":"Seidel M, Kiziler MF, Matiakis M, et al. Predictors of blood pressure response to continuous positive airway pressure treatment in patients with sleep apnea. J Hypertens. 2024;42(5):777\u201382.","journal-title":"J Hypertens"},{"issue":"18","key":"1356_CR27","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/j.jacc.2024.03.359","volume":"83","author":"YH Ou","year":"2024","unstructured":"Ou YH, Colpani JT, Cheong CS, et al. Mandibular Advancement vs CPAP for Blood Pressure Reduction in Patients With Obstructive Sleep Apnea. J Am Coll Cardiol. 2024;83(18):1760\u201372.","journal-title":"J Am Coll Cardiol"},{"key":"1356_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.smrv.2017.10.004","volume":"40","author":"GE de Vries","year":"2018","unstructured":"de Vries GE, Wijkstra PJ, Houwerzijl EJ, Kerstjens HAM, Hoekema A. Cardiovascular effects of oral appliance therapy in obstructive sleep apnea: a systematic review and meta-analysis. Sleep Med Rev. 2018;40:55\u201368.","journal-title":"Sleep Med Rev"},{"issue":"1","key":"1356_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1001\/jamaoto.2023.3756","volume":"150","author":"RC Dedhia","year":"2024","unstructured":"Dedhia RC, Bliwise DL, Quyyumi AA, et al. Hypoglossal nerve stimulation and cardiovascular outcomes for patients with obstructive sleep apnea: a randomized clinical trial. JAMA Otolaryngol Head Neck Surg. 2024;150(1):39\u201348.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"24","key":"1356_CR30","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1056\/NEJMoa1306766","volume":"370","author":"DJ Gottlieb","year":"2014","unstructured":"Gottlieb DJ, Punjabi NM, Mehra R, et al. CPAP versus oxygen in obstructive sleep apnea. N Engl J Med. 2014;370(24):2276\u201385.","journal-title":"N Engl J Med"},{"key":"1356_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2021.101446","volume":"58","author":"G Labarca","year":"2021","unstructured":"Labarca G, Schmidt A, Dreyse J, et al. Efficacy of continuous positive airway pressure (CPAP) in patients with obstructive sleep apnea (OSA) and resistant hypertension (RH): systematic review and meta-analysis. Sleep Med Rev. 2021;58:101446.","journal-title":"Sleep Med Rev"},{"issue":"6","key":"1356_CR32","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1097\/HJH.0000000000002053","volume":"37","author":"C Navarro-Soriano","year":"2019","unstructured":"Navarro-Soriano C, Mart\u00ednez-Garc\u00eda MA, Torres G, et al. Effect of continuous positive airway pressure in patients with true refractory hypertension and sleep apnea: a post-hoc intention-to-treat analysis of the HIPARCO randomized clinical trial. J Hypertens. 2019;37(6):1269\u201375.","journal-title":"J Hypertens"},{"issue":"13","key":"1356_CR33","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","volume":"391","author":"A Malhotra","year":"2024","unstructured":"Malhotra A, Grunstein RR, Fietze I, et al. Tirzepatide for the treatment of obstructive sleep apnea and obesity. N Engl J Med. 2024;391(13):1193\u2013205.","journal-title":"N Engl J Med"},{"issue":"12","key":"1356_CR34","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1093\/sleep\/32.12.1589","volume":"32","author":"A Svatikova","year":"2009","unstructured":"Svatikova A, Olson LJ, Wolk R, et al. Obstructive sleep apnea and aldosterone. Sleep. 2009;32(12):1589\u201392.","journal-title":"Sleep"},{"issue":"1","key":"1356_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.13726","volume":"32","author":"HH Loh","year":"2023","unstructured":"Loh HH, Lim QH, Chai CS, et al. Influence and implications of the renin-angiotensin-aldosterone system in obstructive sleep apnea: an updated systematic review and meta-analysis. J Sleep Res. 2023;32(1):e13726.","journal-title":"J Sleep Res"},{"issue":"3","key":"1356_CR36","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1161\/HYPERTENSIONAHA.118.11170","volume":"72","author":"MA Mart\u00ednez-Garc\u00eda","year":"2018","unstructured":"Mart\u00ednez-Garc\u00eda MA, Navarro-Soriano C, Torres G, et al. Beyond resistant hypertension. Hypertension. 2018;72(3):618\u201324.","journal-title":"Hypertension"},{"issue":"6","key":"1356_CR37","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1378\/chest.07-1170","volume":"132","author":"SC Gon\u00e7alves","year":"2007","unstructured":"Gon\u00e7alves SC, Martinez D, Gus M, et al. Obstructive sleep apnea and resistant hypertension: a case-control study. Chest. 2007;132(6):1858\u201362.","journal-title":"Chest"},{"issue":"12","key":"1356_CR38","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1097\/00004872-200112000-00022","volume":"19","author":"AG Logan","year":"2001","unstructured":"Logan AG, Perlikowski SM, Mente A, et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens. 2001;19(12):2271\u20137.","journal-title":"J Hypertens"},{"issue":"6","key":"1356_CR39","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","volume":"40","author":"DA Calhoun","year":"2002","unstructured":"Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Weissmann P. Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension. 2002;40(6):892\u20136.","journal-title":"Hypertension"},{"issue":"4","key":"1356_CR40","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0272-6386(01)80117-7","volume":"37","author":"BJ Gallay","year":"2001","unstructured":"Gallay BJ, Ahmad S, Xu L, Toivola B, Davidson RC. Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio. Am J Kidney Dis. 2001;37(4):699\u2013705.","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"1356_CR41","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1097\/00004872-200411000-00026","volume":"22","author":"IK Eide","year":"2004","unstructured":"Eide IK, Torjesen PA, Drolsum A, Babovic A, Lilledahl NP. Low-renin status in therapy-resistant hypertension: a clue to efficient treatment. J Hypertens. 2004;22(11):2217\u201326.","journal-title":"J Hypertens"},{"issue":"11 Pt 1","key":"1356_CR42","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S0895-7061(03)01032-X","volume":"16","author":"MK Nishizaka","year":"2003","unstructured":"Nishizaka MK, Zaman MA, Calhoun DA. Efficacy of low-dose spironolactone in subjects with resistant hypertension. Am J Hypertens. 2003;16(11 Pt 1):925\u201330.","journal-title":"Am J Hypertens"},{"issue":"4","key":"1356_CR43","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1161\/01.HYP.0000259805.18468.8c","volume":"49","author":"N Chapman","year":"2007","unstructured":"Chapman N, Dobson J, Wilson S, et al. Effect of spironolactone on blood pressure in subjects with resistant hypertension. Hypertension. 2007;49(4):839\u201345.","journal-title":"Hypertension"},{"issue":"5","key":"1356_CR44","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/jhh.2011.47","volume":"26","author":"T Dudenbostel","year":"2012","unstructured":"Dudenbostel T, Calhoun DA. Resistant hypertension, obstructive sleep apnoea and aldosterone. J Hum Hypertens. 2012;26(5):281\u20137.","journal-title":"J Hum Hypertens"},{"issue":"3","key":"1356_CR45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11906-018-0819-5","volume":"20","author":"B Valaiyapathi","year":"2018","unstructured":"Valaiyapathi B, Calhoun DA. Role of mineralocorticoid receptors in obstructive sleep apnea and metabolic syndrome. Curr Hypertens Rep. 2018;20(3):23.","journal-title":"Curr Hypertens Rep"},{"issue":"12","key":"1356_CR46","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1055\/s-0043-122887","volume":"49","author":"A Prejbisz","year":"2017","unstructured":"Prejbisz A, Ko\u0142odziejczyk-Kruk S, Lenders JWM, Januszewicz A. Primary aldosteronism and obstructive sleep apnea: is this a bidirectional relationship? Horm Metab Res. 2017;49(12):969\u201376.","journal-title":"Horm Metab Res"},{"key":"1356_CR47","doi-asserted-by":"publisher","first-page":"45241","DOI":"10.1038\/srep45241","volume":"7","author":"X Ke","year":"2017","unstructured":"Ke X, Guo W, Peng H, et al. Association of aldosterone excess and apnea-hypopnea index in patients with resistant hypertension. Sci Rep. 2017;7:45241.","journal-title":"Sci Rep"},{"issue":"6","key":"1356_CR48","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1007\/s11325-024-03113-1","volume":"28","author":"AR Schwartz","year":"2024","unstructured":"Schwartz AR, Herpel L, Bogan R, Corser B, Pho H, Taranto-Montemurro L. Atomoxetine and spironolactone combine to reduce obstructive sleep apnea severity and blood pressure in hypertensive patients. Sleep Breath. 2024;28(6):2571\u201380.","journal-title":"Sleep Breath"},{"issue":"6","key":"1356_CR49","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1097\/HJH.0000000000003131","volume":"40","author":"C Kou","year":"2022","unstructured":"Kou C, Zhao X, Lin X, Fan X, Wang Q, Yu J. Effect of different treatments for obstructive sleep apnoea on blood pressure. J Hypertens. 2022;40(6):1071\u201384.","journal-title":"J Hypertens"},{"issue":"8","key":"1356_CR50","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/jhh.2009.96","volume":"24","author":"K Gaddam","year":"2010","unstructured":"Gaddam K, Pimenta E, Thomas SJ, et al. Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report. J Hum Hypertens. 2010;24(8):532\u20137.","journal-title":"J Hum Hypertens"},{"issue":"5","key":"1356_CR51","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3109\/10641963.2015.1131290","volume":"38","author":"L Yang","year":"2016","unstructured":"Yang L, Zhang H, Cai M, et al. Effect of spironolactone on patients with resistant hypertension and obstructive sleep apnea. Clin Exp Hypertens. 2016;38(5):464\u20138.","journal-title":"Clin Exp Hypertens"},{"key":"1356_CR52","doi-asserted-by":"crossref","unstructured":"Krasi\u0144ska B, Cofta S, Szczepaniak-Chiche\u0142 L et al. The effects of eplerenone on the circadian blood pressure pattern and left ventricular hypertrophy in patients with obstructive sleep apnea and resistant Hypertension-A Randomized, controlled trial. J Clin Med. 2019;8(10):1\u201317.","DOI":"10.3390\/jcm8101671"},{"key":"1356_CR53","unstructured":"Mineralys Therapeutics Completes Enrollment in Phase 2 EXPLORE-OSA Trial of Lorundrostat in Obstructive Sleep Apnea and Hypertension. Mineralys Therapeutics, Inc. https:\/\/ir.mineralystx.com\/news-events\/press-releases\/detail\/81\/mineralys-therapeutics-completes-enrollment-in-phase-2. Published 2025. Accessed 2025."}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-025-01356-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11906-025-01356-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-025-01356-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T20:03:53Z","timestamp":1767470633000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11906-025-01356-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,3]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1356"],"URL":"https:\/\/doi.org\/10.1007\/s11906-025-01356-1","relation":{},"ISSN":["1534-3111"],"issn-type":[{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,3]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Mehra has received National Institutes of Health funding (R21 HL170206); has received funds from the Women\u2019s Alzheimer\u2019s Movement for research; funds from Apnimed, Eli Lilly, Mineralys; funds from Pri-med Education, funds from Haymarket Media and royalties from UpToDate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6"}}